Companies: 10,795·Total market cap: $144.5T
Applied DNA Sciences, Inc.

Applied DNA Sciences, Inc.

APDNNASDAQHealthcare
$5.62
+$1.35(+31.62%)
Market Cap$7257454
P/E Ratio
52W High$319.95
52W Low$2.13
Overview

Applied DNA Sciences, Inc. (APDN) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · APDN · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-121.08apdn eps ttm · apdn earnings per shareEarnings history
PE Ratio (TTM)apdn pe ratio ttm · apdn price to earningsPE Ratio deep dive
Revenue (TTM)$1.5Mapdn revenue ttm · apdn annual revenueFull revenue history
Dividend YieldNo Dividenddoes apdn pay dividends · apdn dividend yieldDividend history
Shares Outstanding517,671apdn shares outstanding · apdn floatShares outstanding history
Next EarningsTBAapdn earnings date · apdn next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$2.1M▼ 37.72% YoY
202320242025
applied dna sciences, inc. revenue · apdn revenue 2025
FY 2025Net Income-$69.5M▼ 893.74% YoY
202320242025
applied dna sciences, inc. net income · apdn profit 2025
FY 2025EPS$-134.23▼ 7275.27% YoY
202320242025
apdn eps · applied dna sciences, inc. earnings per share 2025
TTM:Revenue: $1.5MNet Income: -$64.9MEPS: $-121.08View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy4 analystsis apdn a buy · apdn analyst rating
Strong Buy
0
Buy
3
Hold
0
Sell
1
Strong Sell
0
12-Month Price Target
$1.50Low
$5.62Current
$1.50Avg Target73.31% downside
$1.50High
apdn price target · apdn 12 month forecast

Total: 4 · Buy rate: 75.0%

The APDN analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $1.50, representing -73.31% downside from the current price of $5.62.

Stock Performance

Full History
1D+0.00%
1W+53.13%
1M+31.62%
3M+23.52%
YTD-96.97%
1Y-95.98%
5Y-99.99%

About Applied DNA Sciences, Inc.

CEOJames A. Hayward Sc.D.
IPO DateJul 15, 2003
Employees46
CountryUS
Websiteadnas.com

Applied DNA Sciences, Inc. specializes in devising and marketing sophisticated DNA-centric technological solutions across diverse sectors. Its activities encompass nucleic acid-based in vitro diagnost…

what is applied dna sciences, inc. · apdn stock overview · applied dna sciences, inc. company profile · who is applied dna sciences, inc. ceo · apdn NASDAQ · applied dna sciences, inc. headquarters · applied dna sciences, inc. business segments

About Stock Overview & Key Data

Applied DNA Sciences, Inc. (APDN) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Jul 15, 2003. As of the latest trading session, APDN stock price is $5.62, with a market capitalization of $7.3M. The stock has returned -95.98% over the past 12 months and -96.97% year-to-date.

According to 4 Wall Street analysts, the consensus rating for Applied DNA Sciences, Inc. stock is Buy, with an average 12-month price target of $1.50. In fiscal year 2025, Applied DNA Sciences, Inc. reported revenue of $2.1M and net income of -$69.5M. For detailed data — including Applied DNA Sciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Applied DNA Sciences, Inc. (APDN) stock price is $5.62. The stock is traded on NASDAQ under the ticker symbol APDN. The 52-week range is $2.13 – $319.95.

APDN stock priceAPDN quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice